catalent glp-1 paves the way for Novo's US expansion Eli Lilly's $3 Billion GLP-1

Thats more than 30 million people in 2025

doi: 10.1210/jc.2008-0751 103 HaqqLMcFarlaneJDiebergGSmartN

In this role, PBMs serve several functions: negotiating rebates and price discounts with drug manufacturers, processing and adjudicating claims, reimbursing pharmacies for drugs dispensed to patients, structuring pharmacy networks, and designing drug benefit offerings, which includes developing formularies (lists of covered drugs), determining utilization management rules, and establishing cost-sharing requirements

a factor of increased importance for consumers on a weight management journey and those coming off of GLP-1 medications

1 A KFF survey in May 2024 revealed that one in eight respondents took a GLP-1 drug for any reason, and 43% of patients with type 2 diabetes mellitus either were actively taking a GLP-1 agonist or had taken one in the past

For the most part, the process was totally painless, but there were some undeniable hiccups along the way